CTLA-4 was consistently expressed at low levels on CD8+ T cells within tumors, with a mean MFI lower than that observed among tumor-infiltrating and circulating Treg cells in mouse models and human tumors (Figures 1C and 1F). This evidence concerns the gene CD8A and neoplasm.